My Web Dashboard





SEO News: Serono and Syntonix to Pursue the Development of a Long-Acting, Inhaleable FSH Therapy to Treat Infertility (RedNova)

GENEVA, Switzerland and WALTHAM, Massachusetts, September 18 /PRNewswire-FirstCall/ -- - Second Agreement Between Companies Builds on Interferon-beta SynFusion(TM) Program Serono (virt-x: SEO and NYSE: SRA) and Syntonix Pharmaceuticals Inc.

read more...

Related News